Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 5, 2010, Pages 429-437

  Queto, Tulio ^a   Xavier Elsas, Pedro ^b   Gardel, Marcelo Aranha ^a   De Luca, Bianca ^a   Barradas, Mônica ^b   Masid, Daniela ^a   E Silva, Patricia Machado R ^a   Peixoto, Christina A ^a,c   Vasconcelos, Zilton Meira F ^a   Dias, Eliane P ^d   Gaspar Elsas, Maria Ignez ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Centro de Tecnologias Estrategicas Do Nordeste   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Bone marrow; CD95L; Diethylcarbamazine; Eosinophils; Inducible NO synthase

Indexed keywords

DIETHYLCARBAMAZINE; EOTAXIN; FAS LIGAND; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; INTERLEUKIN 5;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW EOSINOPHILIA; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ENZYME REPRESSION; EOSINOPHIL; EOSINOPHILIA; EX VIVO STUDY; GENE TARGETING; IN VIVO STUDY; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TH1 CELL; TH2 CELL; TREATMENT DURATION;

AIRWAY RESISTANCE; ANIMALS; BONE MARROW DISEASES; BRONCHOCONSTRICTOR AGENTS; DIETHYLCARBAMAZINE; EOSINOPHILIA; EOSINOPHILS; FAS LIGAND PROTEIN; FILARICIDES; HEMATOPOIESIS; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE COUNT; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY EOSINOPHILIA;

EID: 77649131949     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200905-0800OC     Document Type: Article

References (27)

1. Maizels RM, Denham DA. Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 1992; 105:S49-S60.
2. Smith HL. Investigating development of infective stage larvae of filarial nematodes. Front Biosci 2000;5:E95-E102.
3. Rajan TV, Forte P, Yates J, Keefer L, Shultz LD. Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi. Infect Immun 1996;64:3351-3353.
4. McGarry HF, Plant LD, Taylor MJ. Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J 2005;4:4.
5. Müller HA, Zahner H. Lethal LPS-independent side effects after microfilaricidal in Acanthocheilonema viteae-infected rodents. Parasitol Res 2005;97:201-208.
6. Rajan TV, Shultz LD, Babu S, Doukas J, Greiner D, Porte P. Diethylcarbamazine (DEC) does not induce nitric oxide (NO) synthesis. Exp Parasitol 1998;88:217-222.
7. Boggild AK, Keystone JS, Kain KC. Tropical pulmonary eosinophilia: a case series in a setting of nonendemicity. Clin Infect Dis 2004;39: 1123-1128.
8. Srinivas HV, Antani J. Diethylcarbamazine in bronchial asthma. Ann Allergy 1971;29:418-421.
9. Mathews WR, Murphy RC. Inhibition of leukotriene biosynthesis in mastocytoma cells by diethylcarbamazine. Biochem Pharmacol 1982; 31:2129-2132.
10. Zuo L, Christofi FL, Wright VP, Bao S, Clanton TL. Lipoxygenasedependent superoxide release in skeletal muscle. J Appl Physiol 2004; 97:661-668.
11. Jones CP, Paula Neto HA, Assreuy J, Vargaftig BB, Gaspar Elsas MI, Xavier Elsas P. Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide- and CD95-dependent pathway. Nitric Oxide 2004;11:184-193.
12. Gaspar-Elsas MI, Queto T, Vasconcelos Z, Jones CP, Lannes-Vieira J, Xavier-Elsas P. Evidence for a regulatory role of a4-integrins in the maturation of eosinophils generated from the bone-marrow in the presence of dexamethasone. Clin Exp Allergy 2009;39:1187-1198.
13. Xavier Elsas P, Queto T, Mendoncxa-Sales SC, Gaspar Elsas MI, Kanaoka Y, Lam BK. Cysteinyl-leukotrienes mediate the enhancing effects of indomethacin and aspirin on eosinophil production in murine bone-marrow culture. Br J Pharmacol 2008;153:528-535.
14. Cyr MM, Denburg JA. Systemic aspects of allergic disease: the role of the bone marrow. Curr Opin Immunol 2001;13:727-732.
15. Gaspar-Elsas MI, Joseph D, Elsas PX, Vargaftig BB. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 1997;17:404-413.
16. Martins GA, Vieira LQ, Cunha FQ, Silva JS. Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun 1999;67:3864-3871.
17. Fonseca BPF, Olsen PC, Coelho LP, Ferreira TPT, Souza HS, Martins MA, Viola JP. NFAT1 transcription factor regulates pulmonary allergic inflammation and airway responsiveness. Am J Respir Cell Mol Biol 2009;40:66-75.
18. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766-775.
19. Gaspar Elsas MI, Maximiano ES, Joseph D, Bonomo A, Vargaftig BB, Xavier Elsas P. Isolation and characterization of hemopoietic cells from lungs of allergic mice. Chest 2003;123:345S-348S.
20. Vasconcelos ZF, Diamond HR, Tabak DG, Barcinski MA, Bonomo A. Th1/Th2 lymphokine profile of T cells present in the blood of granulocyte-colony stimulating factor-treated stem-cell donors: up or down modulation. Blood 2001;97:333-335.
21. Horton MA, Larson KA, Lee JJ, Lee NA. Cloning of the murine eosinophil peroxidase gene (mEPO): characterization of a conserved subgroup of mammalian hematopoietic peroxidases. J Leukoc Biol 1996;60:285-294.
22. Figueredo-Silva J, Jungmann P, Norões J, Piessens WF, Coutinho A, Brito C, Rocha A, Dreyer G. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis. Trans R Soc Trop Med Hyg 1996;90:192-194.
23. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004;305:1773-1776.
24. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, et al. A critical role for eosinophils in allergic airways remodeling. Science 2004;305: 1776-1779.
25. Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 2009;21:97-113.
26. Martin RJ. Mode of action of anthelmintic drugs. Vet J 1997;154:11-34.
27. Harder A. Chemotherapeutic approaches to nematodes: current knowledge and outlook. Parasitol Res 2002;88:272-277.